Published in:
Open Access
01-02-2011 | Poster presentation
Levosimendan in trauma patients with acute cardiac failure
Authors:
AN Afonin, N Karpun
Published in:
Critical Care
|
Special Issue 1/2011
Login to get access
Excerpt
Acute heart failure (AHF) is common among trauma patients with pre-existing coronary artery disease (CAD) and myocardial perfusion defect. The therapy is aimed at increased contractility while decreasing afterload and includes β1-adrenergic agents and phosphodiesterase III inhibitors, which act by increasing the intracellular calcium (Ca) concentration, thus markedly increasing myocardial energy consumption and risk of arrhythmias. The new Ca sensitizer levosimendan enhances cardiac performance without increasing myocardial energy demand and oxygen consumption. We report new use of levosimendan in polytrauma victims with AHF. …